Eiko Lifesciences Ltd Financial Ratios
EIKO · Chemicals · Current price ₹45.26
P/E ratio
24.3x
P/B ratio
1.0x
ROE
8.5%
ROCE
11.1%
Debt / Equity
0.07
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 24.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 8.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 11.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.07 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Eiko Lifesciences Ltd's latest numbers.
Eiko Lifesciences Ltd profitability
Eiko Lifesciences Ltd generates a return on equity of 8.5% and a return on capital employed of 11.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.07 and a P/E of 24.3x, Eiko Lifesciences Ltd is conservatively financed. Our overall business-quality score for the company is 4.9 / 10.
Understand the ratios
More on Eiko Lifesciences Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.